Nordea Investment Management AB Purchases 86,910 Shares of Privia Health Group, Inc. (NASDAQ:PRVA)

Nordea Investment Management AB raised its holdings in Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 33.1% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 349,773 shares of the company's stock after buying an additional 86,910 shares during the quarter. Nordea Investment Management AB owned about 0.29% of Privia Health Group worth $6,953,000 at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. Canada Pension Plan Investment Board purchased a new stake in Privia Health Group in the second quarter worth $26,000. GAMMA Investing LLC lifted its position in shares of Privia Health Group by 98.7% in the 3rd quarter. GAMMA Investing LLC now owns 1,701 shares of the company's stock worth $31,000 after purchasing an additional 845 shares during the period. Quarry LP boosted its stake in shares of Privia Health Group by 344.6% during the 3rd quarter. Quarry LP now owns 3,268 shares of the company's stock valued at $60,000 after purchasing an additional 2,533 shares in the last quarter. KBC Group NV increased its position in shares of Privia Health Group by 34.6% during the third quarter. KBC Group NV now owns 3,385 shares of the company's stock valued at $62,000 after buying an additional 871 shares during the period. Finally, Neo Ivy Capital Management bought a new position in Privia Health Group in the third quarter worth about $66,000. 94.48% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several analysts have weighed in on PRVA shares. Macquarie began coverage on Privia Health Group in a research report on Monday, December 16th. They set an "outperform" rating and a $25.00 price objective on the stock. Stephens restated an "overweight" rating and set a $26.00 price target on shares of Privia Health Group in a research report on Thursday, January 2nd. Needham & Company LLC initiated coverage on Privia Health Group in a report on Friday. They issued a "buy" rating and a $25.00 price objective for the company. KeyCorp assumed coverage on shares of Privia Health Group in a report on Friday, October 11th. They set an "overweight" rating and a $23.00 target price on the stock. Finally, JPMorgan Chase & Co. increased their price target on shares of Privia Health Group from $27.00 to $28.00 and gave the stock an "overweight" rating in a research note on Friday, November 29th. Two equities research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, Privia Health Group presently has a consensus rating of "Buy" and a consensus price target of $24.88.

Privia Health Group Stock Performance

Shares of PRVA stock traded down $0.42 during mid-day trading on Friday, hitting $20.51. The company's stock had a trading volume of 969,204 shares, compared to its average volume of 629,534. The stock has a market cap of $2.46 billion, a price-to-earnings ratio of 205.12, a PEG ratio of 5.45 and a beta of 0.85. Privia Health Group, Inc. has a 52-week low of $15.92 and a 52-week high of $23.24. The business has a 50-day moving average price of $20.93 and a 200 day moving average price of $19.43.

Privia Health Group Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.